TNF Pharmaceuticals Inc (NASDAQ:TNFA) at last check was buoying at $0.17 on current market day with a fall of -1.61% from its closing price on previous day.
Considering stock’s 52-week price range provides that TNFA hit a high price of $2.24 and saw its price falling to a low level of $0.15 during that period. Over a period of past 1-month, stock came subtracting -14.77% in its value.
With its current market valuation of $2.34 million, TNF Pharmaceuticals Inc is set to declare its quarterly results in July. Analysts are in estimates of 0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to 0 for current year with estimates of that growing to 0 in next year.
Digging deeper we become aware of the PEG ratio of the TNFA stock which is currently positioned at 0. It further provides that stock’s current price level is -8.42% away from its 20-day simple moving average and is -29.71% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 39.77 while volatility remained at 4.81% over the past week which changes to 8.03% when measuring it over the past month. Beta is valued at 2.07, while measure of average true range or ATR is currently at 0.02.
The percentage of outstanding shares held by the insiders is 4.98% while it is 1.44% for the institutional holders. Subtraction of -85.64% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
